AXRX Financials 07/15/2014 19:51:00 Amexdrug Corp

AXRX Financials 07/15/2014 19:51:00
Amexdrug Corp.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 8,513 9,149 12,407 11,487
Cost of Revenue 7,523 8,142 11,411 10,524
Gross Profit 990 1,007 996 963
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 1,008 791 768 664
Non-Recurring Items - - - -
Other 59 20 6 8
Operating Income (77) 196 221 290
Income From Continuing Operations
Add'l Income/Expense Items 137 2 (7) 1
Earnings Before Interest and Tax 61 198 214 291
Interest Expense 47 38 27 25
Earnings Before Tax 13 160 187 266
Income Tax (11) 78 86 77
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 24 82 101 189
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 24 82 101 189
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 24 82 101 189